Background and aims
Liver failure syndromes are characterized by a dysregulated immune response leading to immune paralysis. Adrenomedullin (ADM) is a potent vasodilator and immunoregulator. This study aimed to explore the role of…
Targeting the adrenomedullin pathway may be a potential therapy for liver failure
